Developer docs
API playgroundTry for free, no card

Search company profiles

MyAlyce

Full company profile

uuid0027cf9

Namestring
MyAlyce
Legal namestring
MyAlyce Inc.
Websiteurl
myalyce.com
Company typeenum
Private
Founded yearint
2023
Descriptiontext

MyAlyce Inc. is a Los Angeles-based, privately held healthcare technology company that operates Beora, a recovery support platform targeted at individuals recovering from substance use disorders and mental health conditions, and the treatment providers and healthcare systems that serve them. The company was founded in 2023 with backing from the Evergreen Fund and operates with a team of 1–10 employees.

Beora's core offering combines wearable biometric technology with an LLM-Wiki software architecture. The LLM-Wiki functions as a patient's living record, synthesizing inputs from electronic medical records (EMRs), AI agent conversations, biometric vitals, and clinical events into an append-only, source-traceable record that operates above — not in place of — existing EMR systems. The platform uses a three-tier context model (client-safe, staff-only, clinical) to manage data access and privacy, and is structured around a 12-dimension recovery framework intended to address post-discharge disconnection in the substance use and mental health treatment continuum.

The company's go-to-market is an enterprise field-sales motion targeting treatment facilities and healthcare systems, currently in an early-access stage with no public pricing or named customers. Revenue mechanics are presumed to involve recurring software subscriptions, potentially bundled with wearable hardware, though no specific pricing model, contract structure, or revenue figures have been disclosed. No healthcare-specific certifications, regulatory clearances, partnerships, or named customers are present in the available data, representing material diligence gaps for any investor evaluation.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLos Angeles, United States
HQ citystring
Los Angeles
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
recovery support platform, mental health software, substance use treatment, wearable biometric monitoring, behavioral health technology
Product category
Behavioral Health Recovery Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Software and Wearable Technology Platform
TypeSubscription Recurring
Description

Company provides wearable technology and software for people in recovery from substance use and mental health challenges. Revenue likely derived from healthcare provider partnerships and possibly recurring software subscriptions, though specific model not disclosed.

myalyce.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1Beora
Description

A second brain for people in recovery—staying with users across treatment, community, and the years in between. An LLM-Wiki serving as the patient's living record drawn from EMR, agent conversations, vitals, and clinical events.

myalyce.com
Core offering1 text field

MyAlyce sells Beora, a recovery support platform that pairs wearable biometric technology with an LLM-Wiki software layer to support individuals in substance use and mental health recovery. The platform synthesizes data from EMRs, AI agent conversations, vitals, and clinical events into an append-only living patient record, and is sold primarily to treatment providers and healthcare systems via an early access program.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

MyAlyce operates Beora as its primary product — a unified recovery support platform combining wearable technology and software. The platform's core component is the LLM-Wiki, which synthesizes patient data from EMR systems, agent conversations, vitals, and clinical events into an append-only living record. Beora is designed to maintain continuous connection with individuals post-treatment through its '12 dimension wheel' framework, moving beyond episodic treatment to a persistent recovery support system.

Product and service1 record
1Beora
CategoryBehavioral Health Recovery Software
Description

Beora is a recovery support platform that combines wearable biometric technology with an LLM-Wiki software layer to support individuals in substance use and mental health recovery. It synthesizes EMR data, AI agent conversations, vitals, and clinical events into an append-only living patient record with source traceability, and is positioned to deliver continuous biometric insights for overdose and suicide prevention. The platform is offered to treatment providers, healthcare systems, and individuals in recovery via an early access program.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Lionrock delivers online substance use counseling and group support via telehealth, mirroring Beora's emphasis on continuous engagement beyond in-person treatment episodes.

TypeBroad incumbent
Description

Spring Health is a mental health benefit platform for employers covering therapy, coaching, and medication management. It is a broad incumbent competing for the same enterprise contracts in the behavioral health category.

TypeDirect peer
Description

Workit Health provides virtual substance use disorder treatment including medication-assisted treatment and therapy. It is a direct competitor in the SUD recovery space with a similar B2B/B2B2C sales motion to providers, payers, and employers.

4Ophelia
TypeDirect peer
Description

Ophelia provides online medication-assisted treatment for opioid dependence and ongoing recovery care. Like MyAlyce, it targets post-discharge retention and aims to be the persistent layer of support across treatment and recovery.

TypeBroad incumbent
Description

Talkspace is a publicly-traded virtual therapy and psychiatry provider serving consumers, payers, and employers. It is a broad incumbent in digital behavioral health with established enterprise relationships overlapping Beora's buyer set.

TypeDirect peer
Description

Boulder Care delivers telehealth-based opioid use disorder treatment and ongoing recovery support. It directly overlaps MyAlyce's target population and enterprise buyer set (payers and providers) with comparable longitudinal care positioning.

TypeBroad incumbent
Description

Lyra Health provides a mental health platform sold to employers, serving therapy, coaching, and medication management. It competes for the same enterprise buyer wallet with broader mental health coverage than Beora's narrower recovery focus.

TypeDirect peer
Description

Eleanor Health is a value-based outpatient addiction and mental health provider combining in-person and virtual care. Its population health and longitudinal recovery model is structurally similar to MyAlyce's persistent-record positioning.

TypeDirect peer
Description

Pelago (formerly Quit Genius) is a digital substance use and mental health clinic sold to employers and health plans. It directly competes with Beora in employer- and provider-purchased digital recovery support, with overlapping outcomes focus on relapse prevention.

TypeBroad incumbent
Description

Headspace Health (Ginger + Headspace) is a large incumbent in digital mental health sold to employers and payers. It overlaps with Beora in mental health recovery support but at broader scope and with established enterprise distribution.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MyAlyce

Behavioral Health Recovery Softwaremyalyce.com

What MyAlyce does

MyAlyce Inc. is a Los Angeles-based, privately held healthcare technology company that operates Beora, a recovery support platform targeted at individuals recovering from substance use disorders and mental health conditions, and the treatment providers and healthcare systems that serve them. The company was founded in 2023 with backing from the Evergreen Fund and operates with a team of 1–10 employees.

Beora's core offering combines wearable biometric technology with an LLM-Wiki software architecture. The LLM-Wiki functions as a patient's living record, synthesizing inputs from electronic medical records (EMRs), AI agent conversations, biometric vitals, and clinical events into an append-only, source-traceable record that operates above — not in place of — existing EMR systems. The platform uses a three-tier context model (client-safe, staff-only, clinical) to manage data access and privacy, and is structured around a 12-dimension recovery framework intended to address post-discharge disconnection in the substance use and mental health treatment continuum.

The company's go-to-market is an enterprise field-sales motion targeting treatment facilities and healthcare systems, currently in an early-access stage with no public pricing or named customers. Revenue mechanics are presumed to involve recurring software subscriptions, potentially bundled with wearable hardware, though no specific pricing model, contract structure, or revenue figures have been disclosed. No healthcare-specific certifications, regulatory clearances, partnerships, or named customers are present in the available data, representing material diligence gaps for any investor evaluation.

MyAlyce firmographics

Firmographics
Name
MyAlyce
Legal name
MyAlyce Inc.
Website
https://myalyce.com
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Where MyAlyce is headquartered

Location

Headquarters

HQ city
Los Angeles
HQ country
United States
HQ region
North America

Markets served

MyAlyce business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations

Revenue model

  1. Software and Wearable Technology Platform: Company provides wearable technology and software for people in recovery from substance use and mental health challenges. Revenue likely derived from healthcare provider partnerships and possibly recurring software subscriptions, though specific model not disclosed.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

MyAlyce product offering

Product offering

Core offering

MyAlyce sells Beora, a recovery support platform that pairs wearable biometric technology with an LLM-Wiki software layer to support individuals in substance use and mental health recovery. The platform synthesizes data from EMRs, AI agent conversations, vitals, and clinical events into an append-only living patient record, and is sold primarily to treatment providers and healthcare systems via an early access program.

Product overview

MyAlyce operates Beora as its primary product — a unified recovery support platform combining wearable technology and software. The platform's core component is the LLM-Wiki, which synthesizes patient data from EMR systems, agent conversations, vitals, and clinical events into an append-only living record. Beora is designed to maintain continuous connection with individuals post-treatment through its '12 dimension wheel' framework, moving beyond episodic treatment to a persistent recovery support system.

Differentiator

Problem solved

Functional benefit

Brands

  • Beora: A second brain for people in recovery—staying with users across treatment, community, and the years in between. An LLM-Wiki serving as the patient's living record drawn from EMR, agent conversations, vitals, and clinical events.

Products and services

  • Beora Beora is a recovery support platform that combines wearable biometric technology with an LLM-Wiki software layer to support individuals in substance use and mental health recovery. It synthesizes EMR data, AI agent conversations, vitals, and clinical events into an append-only living patient record with source traceability, and is positioned to deliver continuous biometric insights for overdose and suicide prevention. The platform is offered to treatment providers, healthcare systems, and individuals in recovery via an early access program.

Companies that use MyAlyce

Customer profile

Segments2 records

Ideal customer profiles1 record

MyAlyce technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature5 records

MyAlyce partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

MyAlyce competitors and assessment

Company assessment

Direct peers

  • Lionrock Recovery: Lionrock delivers online substance use counseling and group support via telehealth, mirroring Beora's emphasis on continuous engagement beyond in-person treatment episodes.
  • Workit Health: Workit Health provides virtual substance use disorder treatment including medication-assisted treatment and therapy. It is a direct competitor in the SUD recovery space with a similar B2B/B2B2C sales motion to providers, payers, and employers.
  • Ophelia: Ophelia provides online medication-assisted treatment for opioid dependence and ongoing recovery care. Like MyAlyce, it targets post-discharge retention and aims to be the persistent layer of support across treatment and recovery.
  • Boulder Care: Boulder Care delivers telehealth-based opioid use disorder treatment and ongoing recovery support. It directly overlaps MyAlyce's target population and enterprise buyer set (payers and providers) with comparable longitudinal care positioning.
  • Eleanor Health: Eleanor Health is a value-based outpatient addiction and mental health provider combining in-person and virtual care. Its population health and longitudinal recovery model is structurally similar to MyAlyce's persistent-record positioning.
  • Pelago: Pelago (formerly Quit Genius) is a digital substance use and mental health clinic sold to employers and health plans. It directly competes with Beora in employer- and provider-purchased digital recovery support, with overlapping outcomes focus on relapse prevention.

Broad incumbents

  • Spring Health: Spring Health is a mental health benefit platform for employers covering therapy, coaching, and medication management. It is a broad incumbent competing for the same enterprise contracts in the behavioral health category.
  • Talkspace: Talkspace is a publicly-traded virtual therapy and psychiatry provider serving consumers, payers, and employers. It is a broad incumbent in digital behavioral health with established enterprise relationships overlapping Beora's buyer set.
  • Lyra Health: Lyra Health provides a mental health platform sold to employers, serving therapy, coaching, and medication management. It competes for the same enterprise buyer wallet with broader mental health coverage than Beora's narrower recovery focus.
  • Headspace Health: Headspace Health (Ginger + Headspace) is a large incumbent in digital mental health sold to employers and payers. It overlaps with Beora in mental health recovery support but at broader scope and with established enterprise distribution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

MyAlyce social profiles

Digital presence

MyAlyce financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MyAlyce leadership team

Management profile

Number of profiles

Profiles1 record

MyAlyce funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MyAlyce M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MyAlyce

What does MyAlyce do?

MyAlyce sells Beora, a recovery support platform that pairs wearable biometric technology with an LLM-Wiki software layer to support individuals in substance use and mental health recovery. The platform synthesizes data from EMRs, AI agent conversations, vitals, and clinical events into an append-only living patient record, and is sold primarily to treatment providers and healthcare systems via an early access program.

Is MyAlyce a public or private company?

MyAlyce is a private company. It is classified as unknown and is currently operating.

When was MyAlyce founded?

MyAlyce was founded in 2023. It employs 1 to 10 people.

Where is MyAlyce based?

MyAlyce is headquartered in Los Angeles, United States, in the North America region.

How does MyAlyce make money?

One revenue line is on record: software and Wearable Technology Platform.

Who are MyAlyce's main competitors?

Direct peers on record are Lionrock Recovery, Workit Health, Ophelia, Boulder Care, Eleanor Health and Pelago. Broad incumbents are Spring Health, Talkspace, Lyra Health and Headspace Health.

Does MyAlyce have an API?

No public API is recorded for MyAlyce.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales